Get started
Quantum Biopharma Ltd.Quantum Biopharma Ltd.Quantum Biopharma Ltd.

Quantum Biopharma Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

QNTM chart


Full chart

QNTM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪16.34 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−13.76 USD
Net income (FY)
‪−13.52 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪1.89 M‬
Beta (1Y)
1.60

Employees


Employees (FY)
7
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.93 M‬ USD

About QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES


Sector
Health Technology
Industry
Biotechnology
CEO
Zeeshan Saeed
Website
quantumbiopharma.com
Headquarters
Toronto
Founded
1994
FIGI
BBG00L45SFK1
Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

QNTM news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as QNTM.

Frequently Asked Questions


The current price of QNTM is 7.02 USD — it has increased by 2.46% in the past 24 hours. Watch Quantum Biopharma Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Quantum Biopharma Ltd. stocks are traded under the ticker QNTM.
QNTM stock has risen by 14.56% compared to the previous week, the month change is a 17.80% rise, over the last year Quantum Biopharma Ltd. has showed a −77.03% decrease.
QNTM reached its all-time high on Jun 3, 2020 with the price of 910.00 USD, and its all-time low was 2.70 USD and was reached on Dec 20, 2024. View more price dynamics on QNTM chart.
See other stocks reaching their highest and lowest prices.
QNTM stock is 5.63% volatile and has beta coefficient of 1.60. Track Quantum Biopharma Ltd. stock price on the chart and check out the list of the most volatile stocks — is Quantum Biopharma Ltd. there?
Today Quantum Biopharma Ltd. has the market capitalization of ‪16.34 M‬, it has decreased by −8.85% over the last week.
Yes, you can track Quantum Biopharma Ltd. financials in yearly and quarterly reports right on TradingView.
Quantum Biopharma Ltd. is going to release the next earnings report on May 15, 2025. Keep track of upcoming events with our Earnings Calendar.
QNTM net income for the last quarter is ‪−5.21 M‬ USD, while the quarter before that showed ‪−3.86 M‬ USD of net income which accounts for −35.02% change. Track more Quantum Biopharma Ltd. financial stats to get the full picture.
No, QNTM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 28, 2025, the company has 7 employees. See our rating of the largest employees — is Quantum Biopharma Ltd. on this list?
Like other stocks, QNTM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Quantum Biopharma Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Quantum Biopharma Ltd. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Quantum Biopharma Ltd. stock shows the neutral signal. See more of Quantum Biopharma Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.